Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oncologists’ Costs For Three Drugs Would Exceed Reimbursement – GAO

Executive Summary

Acquisition costs for three chemotherapy drugs would exceed projected Medicare reimbursement rates in 2005, a Government Accountability Office analysis using preliminary average sales price data finds
Advertisement

Related Content

CMS Updates 2005 Part B Payment Rates; Gemzar ASP Increases By 7.3%
Medicare Part B Demo, Coding Changes Will Stabilize Oncology Rx Market
Average Sales Price Unveiled; IG Will Monitor Part B Market In 2005
Average Sales Price Unveiled; IG Will Monitor Part B Market In 2005

Topics

Advertisement
UsernamePublicRestriction

Register

PS045068

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel